Polyneuropathies Clinical Trials

37 clinical trials for Polyneuropathies across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Using the EHR to Advance Genomic Medicine Across a Diverse Health System — RECRUITING · NA
• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant — RECRUITING · PHASE3
• A Phase 3 Study of NTLA-2001 in ATTRv-PN — RECRUITING · PHASE3
• Accuracy of the Polymerase Chain Reaction of Ulnar Perineural Subcutaneous Aspirate Guided by Ultrasound for the Diagnosis and Monitoring of Leprosy Cure — RECRUITING · NA
• Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy — RECRUITING
• Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study — RECRUITING
• Diagnostic Feasibility of 100 Hz Tetanic Stimulation — RECRUITING
• Sensory deficiencies in secondary neuropathies, psychiatric and psychosomatic disorders. A pediatric comparative study — RECRUITING
• Prognostic Value of Biomarkers in Polyneuropathy. — RECRUITING
• Exploring the Genetics of Neuropathic Pain — RECRUITING
• To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE) — NOT_YET_RECRUITING · PHASE3
• Is Serum Irisin Level a Biomarker in Diabetic Polyneuropathy? — NOT_YET_RECRUITING
• Single-Center Study Evaluating the Impact of Age on the Diagnostic Performance of the Sural-to-Radial Sensory Amplitude Ratio in Length-Dependent and Non-Length-Dependent Peripheral Polyneuropathies — NOT_YET_RECRUITING
• Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy — COMPLETED · PHASE1
• ChatGPT in the Diagnosis and Management of Complex Polyneuropathies: Comparative Analysis With Neurologists Using Real-World Cases — COMPLETED
• Effect of Exercise and Surgical Weight Loss on Polyneuropathy — COMPLETED · NA
• Individual Patient Expanded Access IND to Treat Polyneuropathy — TERMINATED
• TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects — COMPLETED
• Assessment of Effectiveness and Stimulation Coverage of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Patients with Cervical Lead Placement — OTHER
• Ultrasonography in Diagnosis of Polyneuropathy — NOT_YET_RECRUITING
• Sensory Neuropathy Scores Validated by Quantitative Sensory Testing and Nerve Conduction Studies for Kidney Transplant Recipients — COMPLETED
• Polyneuropathy and COVID-19 — OTHER
• Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer — OTHER
• Physical Activity in Persons With Charcot-Marie-Tooth: Developing a Measurement Instrument — OTHER · NA
• Electrical Muscle Stimulation in the Development of Acquired Weakness in Patients With Severe Sepsis and Septic Shock — COMPLETED · NA
• Peripheral Physiological Measures as Determinants of Pain Risk — OTHER
• Rituximab to Treat Neuropathy With Anti-MAG Antibodies — COMPLETED · PHASE2
• Neurogenic Inflammation in Diabetes — COMPLETED · NA
• National Registry for Egyptian Pediatric Neuromuscular Diseases — OTHER
• Neuropathic Pain Management — COMPLETED · PHASE3
• Cost-effectiveness of In-shoe Pressure Measurement for Therapeutic Shoes — OTHER · NA
• The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis — TERMINATED · PHASE1
• Neurotrophic Factors in Cerebrospinal Fluid in Diabetic Patients With Polyneuropathy — OTHER
• A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy — COMPLETED · PHASE2
• Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain — COMPLETED · PHASE2
• Escitalopram as a Treatment for Pain in Polyneuropathy — COMPLETED · PHASE4
• An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain — TERMINATED · PHASE2

Refine this search